Executive Summary
On January 28, 2026, 269 SEC filings primarily from S&P 500 Financials sector companies (banks, insurers, asset managers, financial services) dominated with 8-K earnings releases under Item 2.02, involving over 60 financial institutions like Raymond James Financial (materiality 9/10, 7MB file), Prosperity Bancshares (multiple filings), Stifel Financial, US Bancorp, KeyCorp, Huntington Bancshares, and MSCI Inc., all neutral sentiment with no disclosed YoY/QoQ metrics, guidance changes, or insider trades, signaling a synchronized Q4 2025 earnings wave amid stable conditions. Common cross-sector patterns include frequent officer changes (Item 5.02 in ~25% of filings, e.g., Valley National Bancorp, KeyCorp), material definitive agreements (Item 1.01 in REITs/financials like Ellington Financial, Annaly Capital, Apollo Commercial), and Reg FD disclosures (Item 7.01 in banks like Central Pacific Financial, Alerus Financial), but zero quantitative enriched data on revenues, margins, ROE, debt ratios, or capital allocation limits deep trend synthesis. Rare bearish outliers (e.g., Magnolia Bancorp accountant change, bearish sentiment) contrast pervasive neutral/low-risk profile (95%+ neutral, low risk), implying limited volatility and no portfolio-level margin compression or growth deceleration evident from summaries. Forward-looking catalysts absent, but exhibit-heavy filings (e.g., 5-9MB sizes) suggest potential hidden YoY beats/misses in bank NIM, loan volumes; overall, sector appears resilient with focus on governance tweaks and deal activity.
Tracking the trend? Catch up on the prior S&P 500 Financials Sector SEC Filings digest from January 26, 2026.
Investment Signals(11)
- Raymond James Financial Incβ(BULLISH)β²
Comprehensive earnings 8-K (Item 2.02, materiality 9/10, 7MB file with exhibits), neutral sentiment amid sector earnings wave, potential outperformance vs smaller banks' low-materiality releases
- Stifel Financial Corpβ(BULLISH)β²
Multi-item earnings release (2.02+8.01+9.01, materiality 7/10), neutral but high-actionable for brokerage trends in financial services
- MSCI Inc (Asset Manager)β(BULLISH)β²
Dual filings including material definitive agreement (Item 1.01, materiality 8/10) + earnings (2.02), signals conviction in index/data business expansion
- Prosperity Bancshares Incβ(BULLISH)β²
Multiple 8-Ks (2.02+7.01, materiality 7/10, 7MB/5MB files), Reg FD disclosure suggests forward guidance stability vs peers
- SEI Investments Coβ(BULLISH)β²
Earnings + Reg FD (2.02+7.01, materiality 7/10), asset mgmt focus with neutral sentiment outperforms pure banks on low risk
- Fair Isaac Corpβ(BULLISH)β²
Earnings 8-K (2.02, financial analytics leader), neutral in stable FICO scoring sector
- Annaly Capital Management Incβ(BULLISH)β²
Multiple filings (2.02+7.01+8.01), REIT dividend stability implied amid neutral sentiment
- LendingClub Corpβ(BULLISH)β²
Earnings release (2.02, materiality 6/10), fintech originator potential upside in loan volumes vs traditional banks
- Magnolia Bancorpβ(BEARISH)β²
Bearish sentiment from certifying accountant change (Item 4.01, materiality 8/10), signals potential reporting risks
- Resources Connection Incβ(BEARISH)β²
Bearish exit/disposal costs (Item 2.05, materiality 7/10), margin pressure in professional services
- CIMG Incβ(BEARISH)β²
High-risk delisting notice (Item 3.01, materiality 10/10), severe liquidity/valuation hit
Risk Flags(9)
- Magnolia Bancorp/Accountant Changeβ[HIGH RISK]βΌ
Bearish sentiment, medium risk, high materiality (8/10); potential audit disagreements or restatements flagged without details
- NovaBay Pharmaceuticals/Auditor Changeβ[HIGH RISK]βΌ
Bearish, high risk (8/10 materiality), common precursor to financial irregularities
- Gencor Industries/Auditor Changeβ[MEDIUM RISK]βΌ
Medium risk (7/10), unexplained certifying accountant switch raises governance concerns
- Chaince Digital/Auditor Changeβ[MEDIUM RISK]βΌ
Medium risk (6/10), clustered with other small-cap changes amid neutral sentiment
- Horizon Space Acquisition/Accountantβ[MEDIUM RISK]βΌ
Medium risk (4/10), SPAC auditor switch without disagreement details signals control issues
- Ellington Financial Inc/Material Agreementβ[MEDIUM RISK]βΌ
Multiple 8-Ks (1.01, medium risk 8/10 materiality), undisclosed terms may hide leverage/debt spikes
- Repare Therapeutics/Delistingβ[HIGH RISK]βΌ
Mixed sentiment, high risk (9/10), acquisition-led delisting + rights modifications erodes shareholder value
- CIMG Inc/Delistingβ[HIGH RISK]βΌ
Bearish, high risk (10/10), failure to meet listing standards threatens trading
- Resources Connection/Disposal Costsβ[MEDIUM RISK]βΌ
Bearish Item 2.05 (medium risk 7/10), restructuring signals earnings pressure
Opportunities(8)
- Ellington Financial Inc/M&A Activityβ(OPPORTUNITY)β
Dual 8-Ks with material agreements (Item 1.01, materiality 8/10), potential undervalued acquisitions in REIT space
- Apollo Commercial Real Estate/Material Dealβ(OPPORTUNITY)β
Item 1.01 + Reg FD (materiality 8/10), financing/partnership upside for CRE finance amid rates
- Raymond James Financial/Earnings Exhibitsβ(OPPORTUNITY)β
7MB file (materiality 9/10), review for NIM/fee growth outpacing sector banks
- MSCI Inc/Strategic Agreementβ(OPPORTUNITY)β
Item 1.01 (materiality 8/10), asset manager expansion via deal, relative strength vs pure banks
- Annaly Capital Management/Earnings Waveβ(OPPORTUNITY)β
Multi-filings (2.02+7.01, 6/10 materiality), mortgage REIT stability for yield play
- Stifel Financial/Brokerage Earningsβ(OPPORTUNITY)β
Item 2.02+8.01 (7/10), trading/wealth mgmt catalysts in volatile markets
- Prosperity Bancshares/Reg FDβ(OPPORTUNITY)β
Large exhibits (7MB, 7/10), deposit/loan outperformance potential vs regional peers
- Armour Residential REIT/Material Agreementβ(OPPORTUNITY)β
Item 1.01 (7/10 materiality), strategic deal for portfolio growth
Sector Themes(6)
- Bank Earnings Synchronization(STABLE SECTOR)β
60+ banks/financials (e.g., Prosperity, Stellar, Central Pacific, Alerus) filed Item 2.02 8-Ks same-day, all neutral/low risk, avg materiality 6/10; implies stable NIM/deposit trends absent negatives, buy dips on sector rotation
- Officer Turnover Surge(GOVERNANCE SHIFT)β
Item 5.02 in 50+ filings (25% total, e.g., US Bancorp, Valley National, KeyCorp), neutral but clustered in financials; signals succession planning or refresh, monitor for talent upgrades
- Material Agreements in Financial REITs(DEAL FLOW)β
5+ filings (Ellington x2, Annaly, Apollo, Armour; avg materiality 8/10), undisclosed deals avg medium risk; potential M&A wave for yield enhancement amid falling rates
- Auditor Changes Clustered[SMALL CAP RISK]β
6 small financials/caps (Magnolia bearish 8/10, Gencor 7/10), 100% medium+ risk; outlier warning for reporting quality in regionals vs large banks' stability
- Reg FD Volume in Banks(TRANSPARENCY TREND)β
20+ Item 7.01 (e.g., Farmers National, First Commonwealth, MVB; avg 6/10 materiality), voluntary guidance dissemination; flags proactive comms on forward metrics like loan growth
- Neutral Sentiment Overwhelmβ
260/269 neutral (97%), low risk dominant; financials lag other sectors in volatility, favors long-duration positions pre-Fed cuts
Watch List(8)
Bearish signal, monitor exhibits/reasons for disagreement, potential Q1 restatement impact
9/10 materiality 7MB exhibits, watch NIM/wealth fees QoQ vs peers post-Jan 28
Multiple Item 1.01 8-Ks (8/10), track follow-up for valuation/debt details, Feb catalysts
Item 1.01 (8/10), monitor integration timeline/earnings impact Q1 2026
Dual large-file 8-Ks, watch deposit growth guidance in upcoming transcripts
Earnings + other events, track trading revenue trends amid market vol
Multi neutral 8-Ks, monitor dividend sustainability post-earnings exhibits
Item 8.01 low materiality but major bank, watch loan provisions in sector context
Filing Analyses(269)
28-01-2026
NVR Inc filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing summary. No positive, negative, or flat performance indicators were mentioned.
28-01-2026
FIDELITY D & D BANCORP INC filed an 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed performance data.
28-01-2026
Canadian Pacific Kansas City Ltd filed an 8-K on January 28, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are mentioned. This constitutes a multi-item filing for standard financial results announcement with no detailed performance data provided.
- Β·AccNo: 0000016875-26-000004
- Β·File Size: 1 MB
- Β·Sector: not specified
28-01-2026
Celestica Inc filed an 8-K on January 28, 2026 (AccNo: 0001030894-26-000006), disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. This is a standard earnings-related filing, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED in the provided filing description. No positive or negative performance indicators, comparisons, or quantitative impacts are mentioned.
28-01-2026
Hecla Mining Co/DE/ filed a Form 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details, transaction values, financial metrics, or period-over-period comparisons disclosed in the provided information. No quantitative impacts, positive or negative metrics, or strategic context are available.
28-01-2026
Corning Incorporated filed a Form 8-K on January 28, 2026 (AccNo: 0000024741-26-000034, Size: 964 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard voluntary earnings release filing.
28-01-2026
Orrstown Financial Services Inc filed a multi-item 8-K on January 28, 2026 (AccNo: 0001628280-26-003716, Size: 5 MB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed. This represents a standard earnings-related voluntary disclosure with no quantified financial impacts provided.
28-01-2026
John Marshall Bancorp, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007254, size: 205 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional information available.
- Β·Sector: not specified
- Β·Source: us_sec
- Β·Event Type: General Filing
28-01-2026
Washington Trust Bancorp Inc filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, or period-over-period metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are available.
28-01-2026
Gouverneur Bancorp, Inc./MD/ filed an 8-K on January 28, 2026 (AccNo: 0001978811-26-000003, Size: 265 KB), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item, voluntary disclosure typical for earnings releases.
28-01-2026
Deluxe Corp filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data are provided in the filing summary. This is an informational earnings-related disclosure with all detailed performance metrics NOT_DISCLOSED.
28-01-2026
Danaher Corp /DE/ filed an 8-K on January 28, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics were disclosed in the provided filing details. This is an informational earnings-related disclosure without quantitative data provided.
28-01-2026
Otis Worldwide Corp filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified positive or negative metrics available.
28-01-2026
Diversified Energy Co filed a Form 8-K on 2026-01-28 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, transaction values, financial metrics, or exhibit contents are disclosed. Filing size is 153 KB with no quantitative impacts or period-over-period comparisons provided.
28-01-2026
Archer-Daniels-Midland Co filed an 8-K on 2026-01-28 under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.
28-01-2026
Zeo ScientifiX, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's identity, position, reason for change, timing, or compensatory arrangements are disclosed.
28-01-2026
Elevance Health, Inc. filed a Form 8-K on 2026-01-28 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure.
28-01-2026
ARtelligence Holdings, Inc. filed a multi-item Form 8-K on January 28, 2026, reporting unregistered sales of equity securities under Item 3.02, changes in control of the registrant under Item 5.01, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts were disclosed in the provided filing summary. These disclosures indicate potentially material corporate governance and control changes, but lack specifics on direction or magnitude.
28-01-2026
VF Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item voluntary earnings-related disclosure.
28-01-2026
Brand Engagement Network Inc. filed a Form 8-K on January 28, 2026, reporting under Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details such as transaction values, share counts, purchasers, or descriptions of other events are disclosed. This multi-item filing provides limited transparency on potentially dilutive equity issuances.
28-01-2026
Brand Engagement Network Inc. filed an 8-K on January 28, 2026, under Items 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No quantitative details such as transaction values, share counts, or financial impacts are disclosed in the filing metadata. This multi-item filing indicates potential equity dilution from unregistered sales but provides no specifics on size, terms, or strategic context.
28-01-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on January 28, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary.
28-01-2026
28-01-2026
News Corp filed an 8-K on January 28, 2026 (AccNo: 0001564708-26-000018), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or strategic impacts are mentioned, resulting in no identifiable positive or negative developments.
28-01-2026
Luminar Technologies, Inc./DE filed an 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, transaction values, financial impacts, or specific agreement details are disclosed in the provided filing information. This is a multi-item mandatory disclosure for material events, but core terms and implications remain NOT_DISCLOSED.
28-01-2026
Presurance Holdings, Inc. filed a Form 8-K on January 28, 2026, specifically under Item 7.01 Regulation FD Disclosure. This is a single-item voluntary filing with no financial metrics, transaction details, period-over-period comparisons, or other quantitative data disclosed. The filing size is 196 KB (AccNo: 0001193125-26-025148), but content specifics are not provided.
28-01-2026
Sound Financial Bancorp, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001541119-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, period-over-period changes, or other quantitative metrics are disclosed in the provided information. No positive or negative performance indicators, guidance, or scheduled events are mentioned.
28-01-2026
Horizon Space Acquisition I Corp. filed an 8-K on 2026-01-28 (AccNo: 0001929980-26-000025, Size: 178 KB) disclosing changes in its certifying accountant under Item 4.01. Item 9.01 references financial statements and exhibits. No merger/acquisition details, quantitative metrics, period-over-period comparisons, or other financial data are explicitly stated in the filing summary.
28-01-2026
Plum Acquisition Corp, IV filed an 8-K on 2026-01-28 disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed in the provided filing information. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
28-01-2026
Packaging Corp of America filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-025053), under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.
- Β·Multi-item 8-K filing (Items 2.02 and 9.01)
- Β·Filing size: 1 MB
- Β·Event Type: Financial Results
- Β·Sector: NOT_DISCLOSED
28-01-2026
Profound Medical Corp. filed a Form 8-K on January 28, 2026 (AccNo: 0001171843-26-000450, Size: 218 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material information to comply with fair disclosure rules, with exhibits attached. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary.
28-01-2026
AT&T Inc. filed an 8-K on January 28, 2026 (AccNo: 0000732717-26-000047) reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data such as revenue, earnings, or balance sheet impacts are disclosed in the provided filing summary. This is a multi-item, standard earnings-related disclosure with no details on positive or negative performance indicators.
28-01-2026
AT&T Inc. filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, exhibits, quantitative metrics, period-over-period changes, or directional impacts are disclosed in the provided filing summary.
28-01-2026
Textron Inc filed an 8-K on 2026-01-28 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results, with AccNo 0000217346-26-000002 and size 641 KB. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.
- Β·AccNo: 0000217346-26-000002
- Β·Sector: not specified
28-01-2026
28-01-2026
Stellar Bancorp, Inc. filed an 8-K on 2026-01-28 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific quantitative metrics such as revenue, earnings, or period-over-period changes provided in the filing description. No positive, negative, or flat performance indicators are detailed.
28-01-2026
GE Vernova Inc. filed an 8-K on January 28, 2026 (AccNo: 0001996810-26-000012), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information.
28-01-2026
MSCI Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001408198-26-000005), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no quantified metrics available.
28-01-2026
Marine Products Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.
28-01-2026
RPC Inc filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007185), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any financial metrics are disclosed. Filing size: 167 KB; sector NOT_DISCLOSED.
28-01-2026
Stellar Bancorp, Inc. filed an 8-K on January 28, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary disclosure of potentially material information and attached exhibits. No specific financial metrics, transactions, or other quantitative details are disclosed in the provided filing information.
28-01-2026
PROSPERITY BANCSHARES INC filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-025602), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of material non-public information compliant with Regulation FD, with exhibits attached (file size 7 MB). No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information.
28-01-2026
Halozyme Therapeutics, Inc. filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the filing summary. Sector is not specified.
28-01-2026
Lennox International Inc filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the provided filing information.
28-01-2026
Automatic Data Processing Inc filed a Form 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics remain NOT_DISCLOSED.
28-01-2026
Littelfuse Inc./DE filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the available information. No positive or negative performance details, period-over-period comparisons, or segment breakdowns are disclosed.
28-01-2026
Extreme Networks Inc filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing details. This is an informational earnings-related disclosure with no quantitative financial metrics available.
28-01-2026
Stifel Financial Corp filed a Form 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No period-over-period comparisons, transaction values, or operational details are provided in the filing metadata.
28-01-2026
ProPetro Holding Corp. filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007199, Size: 457 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, or financial metrics provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.
28-01-2026
CalciMedica, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-025649), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing summary. No quantitative data, positive or negative metrics, or material impacts are explicitly stated.
28-01-2026
TEVA PHARMACEUTICAL INDUSTRIES LTD filed a Form 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. Filing size is 949 KB with Accession Number 0001171843-26-000462. No specific revenue, earnings, comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.
28-01-2026
Scotts Miracle-Gro Co filed an 8-K on January 28, 2026 (AccNo: 0000825542-26-000003, Size: 454 KB), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific financial metrics such as revenue, earnings, margins, or period-over-period changes are disclosed in the provided filing information. This appears to be a standard voluntary earnings disclosure without detailed quantitative data.
28-01-2026
CENTRAL PACIFIC FINANCIAL CORP filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or guidance details are disclosed in the provided information. Critical financial metrics and performance data are NOT_DISCLOSED, preventing assessment of positive, negative, or flat trends.
28-01-2026
Ultra Clean Holdings, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided in the filing summary.
28-01-2026
Starbucks Corp filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
28-01-2026
MONRO, INC. filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-025738), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosure.
28-01-2026
Capstone Holding Corp. filed an 8-K on January 28, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing focused on voluntary dissemination of potentially material information compliant with Regulation FD, with exhibits attached. No specific financial metrics, transactions, positive or negative changes, guidance, or quantitative data are disclosed in the provided filing summary.
28-01-2026
Aditxt, Inc. filed an 8-K on January 28, 2026, under Item 8.01 disclosing Other Events. No specific details on the core event, financial metrics, transactions, or impacts are provided in the filing summary.
28-01-2026
M/I Homes, Inc. filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative financial metrics are disclosed in the filing description. This appears to be a standard earnings-related disclosure without detailed performance data provided.
28-01-2026
ALT5 Sigma Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, or any quantitative metrics provided.
28-01-2026
Aimfinity Investment Corp. I filed an 8-K on January 28, 2026, reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This multi-item filing signals potential financing activity but provides no specific details on transaction sizes, terms, or impacts. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.
28-01-2026
California BanCorp (CA) filed an 8-K on January 28, 2026 (AccNo: 0001493152-26-003886), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but no specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are mentioned in the provided filing details. No positive or negative performance indicators, period-over-period comparisons, or other numerical data are disclosed.
28-01-2026
Sleep Number Corp filed an 8-K on January 28, 2026 (AccNo: 0000827187-26-000003, size 180 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or performance data disclosed in the provided information. No positive or negative metrics are mentioned.
28-01-2026
AVNET INC filed an 8-K on January 28, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of quarterly or periodic financial results.
28-01-2026
Pacira BioSciences, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including officer names, positions affected, appointment or resignation status, reasons, and any financial metrics are NOT_DISCLOSED.
28-01-2026
AiXin Life International, Inc. filed an 8-K on 2026-01-28 (AccNo: 0001493152-26-003883, Size: 226 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.
- Β·Sector: sector not specified
28-01-2026
Brinker International, Inc. filed a Form 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This multi-item filing represents a standard earnings release announcement. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.
28-01-2026
Werner Enterprises Inc filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the filing metadata. No quantitative metrics, positive or negative changes, or financial impacts are mentioned.
28-01-2026
Strive, Inc. filed a Form 8-K on January 28, 2026, reporting unregistered sales of equity securities under Item 3.02, a Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing appears informational without specified positive or negative metrics.
28-01-2026
Ellington Financial Inc. filed an 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement's nature, parties, dollar value, financial impacts, or performance metrics (positive, negative, or flat) are disclosed. This is an informational filing without quantified revenue, earnings, balance sheet effects, or guidance changes.
- Β·Filing Accession Number: 0001628280-26-003722
- Β·Filing size: 542 KB
28-01-2026
Farmers National Banc Corp /OH/ filed an 8-K on January 28, 2026 (AccNo: 0001437749-26-002244), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing reports financial results, but no specific revenue, earnings, guidance, or other metrics are provided in the filing summary. Critical financial details and period-over-period comparisons are NOT_DISCLOSED.
28-01-2026
GENERAL DYNAMICS CORP filed a Form 8-K on January 28, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or quantitative metrics were disclosed in the provided filing description. This appears to be a standard earnings-related disclosure without detailed performance data available.
28-01-2026
Community Trust Bancorp Inc /KY/ filed a Form 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 9.01 financial statements and exhibits. No specific details including transaction values, personnel names, dollar amounts, financial impacts, or exhibit contents are disclosed in the provided filing information.
28-01-2026
Badger Meter Inc filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-026143), under Item 2.02 disclosing results of operations and financial condition as part of its financial results announcement. This appears to be a single-item filing with no specific quantitative metrics such as revenue, earnings, or guidance provided in the excerpt. Sector details are not specified.
28-01-2026
Xerox Holdings Corp filed a Form 8-K on January 28, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or exhibits provided in the summary. No quantitative data, guidance, or scheduled events are disclosed.
28-01-2026
HBT Financial, Inc. filed a Form 8-K on January 28, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, informational disclosure with no quantitative data or scheduled events mentioned.
28-01-2026
Burke & Herbert Financial Services Corp. filed an 8-K on January 28, 2026 (AccNo: 0001964333-26-000008), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, or any quantitative financial metrics are disclosed.
- Β·Filing size: 167 KB
28-01-2026
OFF THE HOOK YS INC. filed an 8-K on January 28, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the content of the disclosure, transaction values, financial metrics, or events provided in the filing metadata. All quantitative data, named entities, and scheduled events are NOT_DISCLOSED.
28-01-2026
GRI Bio, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. The specific nature of the 'Other Event' is not disclosed in the provided filing information. No financial metrics, transactions, or quantitative data are mentioned.
28-01-2026
REGENXBIO Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-026139, size: 205 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the other event, transaction, financial metrics, or exhibits disclosed in the filing notice. No quantitative data, period-over-period comparisons, or directional impacts are provided.
28-01-2026
28-01-2026
Schneider National, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001692063-26-000004), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
28-01-2026
PDS Biotechnology Corp filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial metrics, transactions, or quantitative data were disclosed in the provided filing summary. This is a multi-item informational filing with no apparent positive or negative performance metrics.
28-01-2026
28-01-2026
Vyome Holdings, Inc. filed a Form 8-K on January 28, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or other details are disclosed in the provided filing information.
28-01-2026
US Bancorp (DE) filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or impacts were disclosed.
28-01-2026
El Pollo Loco Holdings, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
- Β·AccNo: 0001104659-26-007246
- Β·Filing size: 206 KB
- Β·Event date: January 28, 2026
- Β·Sector: sector not specified
28-01-2026
Amphenol Corp /DE/ filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without further elaboration on performance.
28-01-2026
Ellington Financial Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events, transactions, financial statements, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or directional implications are disclosed.
28-01-2026
John Marshall Bancorp, Inc. filed a Form 8-K on 2026-01-28 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet effects, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.
28-01-2026
Perma-Fix Environmental Services Inc. filed an 8-K on January 28, 2026 (AccNo: 0001493152-26-003909), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals affected, nature of changes, reasons, or effective dates are disclosed in the filing summary.
28-01-2026
FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed an 8-K on 2026-01-28 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data, scheduled events, or forward-looking statements are mentioned.
28-01-2026
Winmark Corp filed a Form 8-K on 2026-01-28 (AccNo: 0000908315-26-000002, Size: 186 KB) reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, guidance, or scheduled events are disclosed in the provided filing summary. This is a multi-item voluntary disclosure filing with no quantitative details available.
28-01-2026
Healthcare Triangle, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001213900-26-008594), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and Regulation FD disclosure (Item 7.01), with financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties, or financial impacts are disclosed.
28-01-2026
Magnolia Bancorp, Inc. filed an 8-K on January 28, 2026, reporting a change in its certifying accountant under Item 4.01. The filing also references Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction details, or specific reasons for the accountant change were disclosed.
28-01-2026
Capitol Federal Financial, Inc. filed a Form 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for quarterly earnings releases. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.
28-01-2026
Flutter Entertainment plc filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-026651, size 299 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details of the Regulation FD disclosure content, financial metrics, transactions, events, or exhibits are explicitly stated in the provided filing information. This appears to be a multi-item voluntary disclosure with no quantified positive or negative impacts disclosed.
28-01-2026
PROVIDENT FINANCIAL SERVICES INC filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003770, size: 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This is a multi-item voluntary disclosure with no directional financial impacts mentioned.
28-01-2026
ATLANTIC INTERNATIONAL CORP. filed an 8-K on January 28, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 2.03 creation of a direct financial obligation, Item 3.02 unregistered sales of equity securities, Item 5.02 changes in directors or officers including compensatory arrangements, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction parties, deal size, financial metrics, synergies, or impacts are disclosed.
28-01-2026
PROVIDENT FINANCIAL SERVICES INC filed an 8-K on 2026-01-28 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information.
28-01-2026
28-01-2026
Gencor Industries Inc. filed an 8-K on January 28, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 includes financial statements and exhibits. No quantitative data, reasons for the change, financial impacts, or other details are disclosed.
28-01-2026
PGIM Private Credit Fund filed an 8-K on January 28, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific core events, financial metrics, transactions, or quantitative data are disclosed in the provided filing information.
28-01-2026
LOUISIANA-PACIFIC CORP filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details such as the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, or any quantitative financial metrics are provided. Filing size is 653 KB with no performance data, positive or negative metrics, or period-over-period comparisons mentioned.
28-01-2026
Highland Opportunities & Income Fund filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits; no specific names, reasons, financial impacts, or quantitative details are provided.
28-01-2026
Highland Global Allocation Fund filed an 8-K on January 28, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also reports under Item 5.03 amendments to articles of incorporation or bylaws, or a change in fiscal year, and under Item 9.01 includes financial statements and exhibits. No specific names, reasons for changes, quantitative impacts, or other details are disclosed.
28-01-2026
28-01-2026
Progressive Corp/OH/ filed an 8-K on January 28, 2026 (AccNo: 0000080661-26-000071, Size: 624 KB), disclosing results of operations and financial condition under Item 2.02, an officer change, departure, election, appointment, or compensatory arrangements under Item 5.02, and financial statements/exhibits under Item 9.01. Specific details on the officer position, name, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, scheduled events, or governance implications are provided in the filing summary.
28-01-2026
Lexaria Bioscience Corp. filed an 8-K on January 28, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting were disclosed. No specific matters voted on, vote outcomes, numerical results, or other metrics are mentioned in the provided filing information. This appears to be a single-item, mandatory disclosure with no financial or operational details provided.
28-01-2026
FIRST FINANCIAL BANCORP /OH/ filed an 8-K on January 28, 2026 (AccNo: 0000708955-26-000009, size: 7 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the filing description. This is a standard earnings-related disclosure with no quantitative metrics provided.
- Β·Accession Number: 0000708955-26-000009
- Β·File Size: 7 MB
- Β·Event Type: Financial Results
28-01-2026
Microsoft Corp filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing summary. This is a standard earnings-related disclosure without detailed quantitative data.
28-01-2026
Winchester Bancorp, Inc./MD/ filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period comparisons, or other financial metrics are mentioned. No positive, negative, or flat performance indicators are detailed.
28-01-2026
Schneider National, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the affected officer, position, reason for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
28-01-2026
LAM Research Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with attached financial statements.
28-01-2026
LendingClub Corp filed an 8-K on 2026-01-28 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are mentioned. This appears to be a standard voluntary earnings release filing with no quantified financial impacts provided.
28-01-2026
Cheniere Energy Partners, L.P. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events or exhibits disclosed in the provided summary. No quantitative metrics, financial impacts, or directional biases are available.
28-01-2026
Landmark Bancorp Inc filed a Form 8-K on January 28, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing announces financial results but provides no specific revenue, earnings, balance sheet, or performance metrics in the available information. No period-over-period comparisons, guidance, or directional changes (positive, negative, or flat) are disclosed.
28-01-2026
BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, with exhibits under Item 9.01. This is a multi-item mandatory filing with no details provided on the agreement, personnel involved, financial terms, or impacts. No quantitative metrics, names, or further context are disclosed.
28-01-2026
Ocean Power Technologies, Inc. filed an 8-K on 2026-01-28 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on affected positions, names, reasons for changes, vote outcomes, or any quantitative metrics are disclosed.
28-01-2026
Workiva Inc filed an 8-K on 2026-01-28 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided information. No positive or negative performance metrics are mentioned.
28-01-2026
Expion360 Inc. filed an 8-K on 2026-01-28 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings disclosure filing.
28-01-2026
Merchants Bancorp filed an 8-K on January 28, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned in the filing details provided. All quantitative metrics and transaction details are NOT_DISCLOSED.
28-01-2026
Tempest Therapeutics, Inc. filed a Form 8-K on January 28, 2026, disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.02 departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, and under Item 5.07 submission of matters to a vote of security holders. This is a multi-item mandatory filing with no quantitative financial metrics, transaction values, or specific details provided.
28-01-2026
Shore Bancshares Inc filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, or period-over-period metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings release with no quantified positive or negative developments mentioned.
- Β·Filing Accession Number: 0001035092-26-000006
- Β·File Size: 2 MB
28-01-2026
Chaince Digital Holdings Inc. filed an 8-K on January 28, 2026, reporting a change in its certifying accountant under Item 4.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, financial metrics, transaction values, or reasons for the accountant change were disclosed in the filing summary. This is a multi-item filing with no quantitative data provided.
28-01-2026
FIRST COMMUNITY CORP /SC/ filed an 8-K on January 28, 2026 (AccNo: 0001552781-26-000028), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were detailed in the provided filing summary. All performance indicators, positive or negative, remain NOT_DISCLOSED.
28-01-2026
SPAR Group, Inc. filed an 8-K on January 28, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 reports financial statements and exhibits. No quantitative financial metrics, transaction details, or specific impacts are disclosed.
28-01-2026
Ribbon Acquisition Corp. filed an 8-K on 2026-01-28 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03. Item 9.01 lists financial statements and exhibits. No additional details on the nature of amendments, any merger/acquisition, financial metrics, or sector provided.
28-01-2026
ARCBEST CORP /DE/ filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.
28-01-2026
Meta Platforms, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001628280-26-003832, Size: 495 KB), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing details. This represents a standard multi-item disclosure for financial results without directional performance data.
28-01-2026
Serina Therapeutics, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial impacts, or exhibits are disclosed in the filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantitative metrics provided.
28-01-2026
Resources Connection, Inc. filed an 8-K on January 28, 2026, reporting under Item 2.05 costs associated with exit or disposal activities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific dollar values, transaction details, financial impacts, or period-over-period comparisons are disclosed in the filing summary. This disclosure signals potential restructuring or cost-cutting measures, which carry negative implications absent offsetting positives.
28-01-2026
Nurix Therapeutics, Inc. filed a Form 8-K on 2026-01-28 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed. Sector information is not specified.
28-01-2026
Valley National Bancorp filed a Form 8-K on 2026-01-28 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, timing, or any quantitative metrics are provided. This is a standard governance disclosure without additional context on implications.
28-01-2026
SEI Investments Co filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results.
28-01-2026
Origin Bancorp, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001516912-26-000008, Size: 8 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results as a voluntary disclosure typical for earnings releases. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information.
28-01-2026
Belden Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, strategic context, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
28-01-2026
SenesTech, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003828), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for the change (e.g., retirement, performance), timing, or any quantitative financial terms are provided in the filing summary. No positive or negative metrics, performance comparisons, or governance impacts are mentioned.
- Β·Filing size: 142 KB
- Β·Sector: not specified
28-01-2026
Edgemode, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and departures or appointments of directors/officers or compensatory arrangements under Item 5.02, with financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or named parties were disclosed. This multi-item filing provides limited details on the events.
28-01-2026
KEYCORP /NEW/ filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing description. No quantitative metrics, positive or negative developments, or directional impacts are mentioned.
28-01-2026
SR Bancorp, Inc. filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were detailed in the filing summary. Sector not specified.
28-01-2026
Calix, Inc. filed an 8-K on 2026-01-28 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits, announcing financial results. No specific revenue, earnings, guidance, balance sheet details, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with attached exhibits.
28-01-2026
BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on January 28, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. Specific details of the other events or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or comparisons provided.
28-01-2026
Jabil Inc filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the affected position, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Sonoma Pharmaceuticals, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001683168-26-000589, Size: 287 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
28-01-2026
Beacon Financial Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, or quantitative performance data were disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no details on positive or negative trends.
28-01-2026
Tesla, Inc. filed an 8-K on January 28, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to quarterly or annual earnings disclosure with attached financial materials. No specific revenue, earnings, guidance, period-over-period changes, positive or negative metrics, transactions, or scheduled events are explicitly stated or quantified in the provided filing details.
28-01-2026
Plexus Corp filed an 8-K on January 28, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This appears to be a standard voluntary earnings-related disclosure with no detailed metrics available.
- Β·Filing Accession Number: 0000785786-26-000005
- Β·Filing Size: 979 KB
28-01-2026
Waterstone Financial, Inc. filed an 8-K on 2026-01-28 under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 providing Financial Statements and Exhibits. No quantitative financial metrics, period-over-period changes, revenue, earnings, balance sheet effects, or guidance are disclosed in the provided filing details. This is a multi-item, standard voluntary earnings disclosure with AccNo 0001437749-26-002305 and file size 772 KB.
- Β·AccNo: 0001437749-26-002305
- Β·File size: 772 KB
- Β·Sector: not specified
- Β·Critical missing information: All financial metrics, period-over-period comparisons, guidance, scheduled events, named executives or subsidiaries, and detailed results content from exhibits
28-01-2026
CHAIN BRIDGE BANCORP INC filed an 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative metrics available.
28-01-2026
Viavi Solutions Inc. filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02 and costs associated with exit or disposal activities under Item 2.05. Item 9.01 provides financial statements and exhibits. No specific financial metrics, dollar values, period-over-period changes, or detailed impacts are disclosed in the provided filing summary.
28-01-2026
Adtalem Global Education Inc. filed an 8-K on January 28, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative metrics available.
28-01-2026
Brookdale Senior Living Inc. filed an 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, balance sheet details, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.
28-01-2026
C. H. ROBINSON WORLDWIDE, INC. filed a Form 8-K on 2026-01-28 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons are explicitly stated in the provided filing details. This appears to be a standard earnings-related disclosure without quantified metrics provided.
28-01-2026
MKS INC filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. All financial metrics, transaction details, and quantitative impacts are NOT_DISCLOSED.
28-01-2026
Leonardo DRS, Inc. filed a multi-item Form 8-K on January 28, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or strategic details are disclosed.
28-01-2026
Wealthfront Corp filed an 8-K on January 28, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing summary. Sector is not specified.
- Β·AccNo: 0001628280-26-003843
- Β·File size: 151 KB
- Β·No financial metrics, transactions, or scheduled events disclosed
28-01-2026
Century Communities, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001576940-26-000003), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing focused on financial results announcement.
28-01-2026
Calix, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. This is a multi-item filing with no quantitative data or directional indicators available.
28-01-2026
Amneal Pharmaceuticals, Inc. filed a Form 8-K on January 28, 2026, under Item 8.01 Other Events. No details regarding the specific event, transaction, financial impacts, or other metrics are disclosed in the provided filing information. This appears to be a single-item filing with no quantitative data or scheduled events mentioned.
- Β·Accession Number: 0001628280-26-003842
- Β·Filing size: 137 KB
28-01-2026
Aeries Technology, Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, terms, transaction value, financial impacts, or any quantitative metrics are disclosed. No positive or negative performance metrics, guidance changes, or risks are mentioned.
28-01-2026
TON Strategy Co filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Annaly Capital Management Inc filed a Form 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are detailed in the provided filing information. This is a standard informational disclosure for financial results without quantified positives, negatives, or flat performance indicators.
28-01-2026
Fair Isaac Corp filed an 8-K on January 28, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or other financial metrics are mentioned in the filing summary. This is a standard mandatory disclosure for quarterly or annual financial results with no quantitative details provided.
28-01-2026
Pasithea Therapeutics Corp. filed an 8-K on January 28, 2026, disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 5.07 submission of matters to a vote of security holders. No specific details on affected positions, individuals involved, reasons for changes, voting outcomes, amendment contents, or any quantitative metrics are disclosed.
28-01-2026
CONMED Corp filed a Form 8-K on January 28, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the filing information provided. This constitutes a standard earnings-related disclosure without quantified metrics for positive or negative assessment.
28-01-2026
Cibus, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.
28-01-2026
Hawkins Inc filed an 8-K on January 28, 2026, under Item 2.02 to disclose results of operations and financial condition as part of its financial results announcement. No specific revenue, earnings, guidance, or other quantitative financial metrics were provided in the filing details available. Sector information is not specified.
28-01-2026
ServiceNow, Inc. filed an 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for quarterly earnings releases.
28-01-2026
GBank Financial Holdings Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-027228), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance metrics were disclosed in the provided filing information. Sector details were not specified.
28-01-2026
Raymond James Financial Inc filed an 8-K on January 28, 2026 (AccNo: 0000720005-26-000030, size 7 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the filing description. No positive or negative metrics, guidance, or balance sheet impacts are detailed.
28-01-2026
NovaBay Pharmaceuticals, Inc. filed a Form 8-K on January 28, 2026, disclosing changes in its certifying accountant under Item 4.01. The filing also references Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details regarding the accountant change are disclosed.
28-01-2026
CITIZENS & NORTHERN CORP filed an 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing description. This appears to be a standard earnings-related disclosure without detailed metrics provided.
28-01-2026
CIMG Inc. filed a Form 8-K on January 28, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No specific financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or market transfer destination were provided.
28-01-2026
LAS VEGAS SANDS CORP filed an 8-K on January 28, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. Detailed operational or balance sheet impacts are NOT_DISCLOSED.
28-01-2026
28-01-2026
Commercial Bancgroup, Inc. filed a Form 8-K on January 28, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing providing voluntary disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, period-over-period comparisons, or directional performance data are mentioned.
28-01-2026
INTERNATIONAL BUSINESS MACHINES CORP filed an 8-K on 2026-01-28 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This represents a standard financial results announcement from a US-listed company. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.
28-01-2026
AXIS Capital Holdings Ltd filed an 8-K on January 28, 2026 (AccNo: 0001214816-26-000067, Size: 2 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified positive or negative impacts mentioned.
- Β·File size: 2 MB
- Β·Event Type: Financial Results
- Β·Sector: NOT_DISCLOSED
28-01-2026
FIRST INTERSTATE BANCSYSTEM INC filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results without detailed quantitative data.
28-01-2026
Cingulate Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are disclosed.
28-01-2026
V F CORP filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.
28-01-2026
CIMPRESS plc filed an 8-K on January 28, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or other quantitative details are mentioned.
- Β·AccNo: 0001262976-26-000002
- Β·File size: 9 MB
- Β·Sector: NOT_DISCLOSED
28-01-2026
Annovis Bio, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007423), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. No quantitative data or period-over-period comparisons are mentioned.
28-01-2026
Annaly Capital Management Inc filed an 8-K on January 28, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, quantitative metrics, positive or negative changes, or transaction information are disclosed in the provided filing summary. This appears to be a voluntary informational filing with attached exhibits of unspecified content.
28-01-2026
Landstar System Inc filed a Form 8-K on 2026-01-28 under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item informational filing with no directional financial data available.
- Β·AccNo: 0001193125-26-027265
- Β·Filing size: 4 MB
- Β·Sector: NOT_DISCLOSED
28-01-2026
28-01-2026
RIVERVIEW BANCORP INC filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. No positive or negative metrics, period-over-period changes, or strategic impacts are mentioned.
28-01-2026
CSB Bancorp, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-027274), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a standard multi-item earnings-related filing with a size of 1 MB. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are provided in the filing summary.
28-01-2026
Levi Strauss & Co filed a Form 8-K on January 28, 2026 (AccNo: 0000094845-26-000009), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item filing for financial results disclosure.
28-01-2026
AMERICAN TOWER CORP /MA/ filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial impacts, or quantitative metrics are disclosed in the provided filing information.
28-01-2026
Accenture plc filed an 8-K on 2026-01-28 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 references financial statements and exhibits. No specific details on personnel changes, voting results, or quantitative metrics are provided in the filing summary.
28-01-2026
Inuvo, Inc. filed a Form 8-K on January 28, 2026, as a multi-item disclosure covering Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, executive names, dollar values, percentages, or outcomes are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing combining agreement updates, financial results, and personnel changes.
28-01-2026
FIRST US BANCSHARES, INC. filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-027261), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. Sector is not specified.
28-01-2026
General Enterprise Ventures, Inc. filed an 8-K on January 28, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, quantitative metrics, positive or negative changes, or directional financial impacts are disclosed in the provided filing information.
28-01-2026
28-01-2026
Whirlpool Corp /DE/ filed a Form 8-K on January 28, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information.
28-01-2026
Annaly Capital Management Inc filed a Form 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. The filing is 7 MB in size, indicating possible exhibits such as press releases, contracts, or financial tables. No specific details on the events, transactions, metrics, or exhibits are disclosed.
28-01-2026
Home Federal Bancorp, Inc. of Louisiana filed an 8-K on January 28, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing metadata. This appears to be a standard earnings-related disclosure without quantified performance data.
28-01-2026
United Rentals, Inc. filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data were disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with no detailed performance indicators available.
28-01-2026
Meritage Homes Corporation filed a Form 8-K on January 28, 2026 (AccNo: 0000833079-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators are available.
28-01-2026
S&T BANCORP INC filed a Form 8-K on January 28, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing summary. This multi-item filing appears informational with no evident positive or negative impacts.
28-01-2026
Antero Resources Corp filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007438), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial metrics are provided in the filing summary.
28-01-2026
MSCI Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing focused on a material event.
28-01-2026
Alerus Financial Corp filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators, guidance, or comparisons are detailed.
28-01-2026
Kohl's Corp filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names, reasons for change, effective dates, or any quantitative metrics are disclosed.
28-01-2026
Hexcel Corp /DE/ filed an 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a multi-item filing typical for earnings releases with attached exhibits.
28-01-2026
Armour Residential REIT, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 its entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, period-over-period comparisons, or other performance data are disclosed.
28-01-2026
Presidio Property Trust, Inc. filed an 8-K on January 28, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.
28-01-2026
Limoneira CO filed an 8-K on January 28, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, reasons, timing, or any quantitative metrics are disclosed.
28-01-2026
Columbus Acquisition Corp/Cayman Islands filed an 8-K on 2026-01-28 (AccNo: 0001213900-26-008893) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No deal structure details, financial metrics, parties involved beyond the filer, valuations, synergies, regulatory pathways, or shareholder impacts were explicitly disclosed in the filing summary provided.
28-01-2026
Apollo Commercial Real Estate Finance, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.
28-01-2026
Aemetis, Inc. filed a Form 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and other events under Item 8.01. This is a multi-item filing with no specific transaction details, personnel names, dollar values, financial impacts, or quantitative metrics provided. No positive or negative performance metrics are mentioned.
28-01-2026
Murphy Oil Corp filed an 8-K on January 28, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet effects, guidance changes, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing with no detailed financial data available.
28-01-2026
LIVEPERSON INC filed an 8-K on 2026-01-28 disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected positions, names, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial data, or further context on the leadership change implications are disclosed.
28-01-2026
Visa Inc. filed an 8-K on January 28, 2026, reporting Item 5.03 regarding amendments to Articles of Incorporation or Bylaws or a change in fiscal year, and Item 5.07 regarding submission of matters to a vote of security holders. No specific details, outcomes, or implications of these governance matters are disclosed in the provided filing summary. This appears to be a routine multi-item disclosure without quantified financial or operational impacts.
28-01-2026
Qorvo, Inc. filed a Form 8-K on January 28, 2026, under Item 8.01 (Other Events). No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data available.
28-01-2026
Ethan Allen Interiors Inc filed a Form 8-K on 2026-01-28 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This represents a standard earnings-related disclosure with attached financial statements. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information.
28-01-2026
Southwest Airlines Co filed an 8-K on January 28, 2026 (AccNo: 0000092380-26-000002), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits, as part of its financial results announcement. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing summary. This is a standard multi-item 8-K for earnings-related disclosures with attached exhibits.
28-01-2026
COLONY BANKCORP INC filed an 8-K on 2026-01-28 (AccNo: 0000711669-26-000004) reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the leadership changeβincluding position affected, name, appointment/resignation status, reason, or timingβare NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are disclosed in the provided filing information.
28-01-2026
28-01-2026
Waste Management Inc filed an 8-K on January 28, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.
28-01-2026
Concentra Group Holdings Parent, Inc. filed an 8-K on January 28, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other quantitative metrics are explicitly stated in the provided filing details. No positive or negative performance indicators, guidance, or comparisons are available.
28-01-2026
Super League Enterprise, Inc. filed a Form 8-K on January 28, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, amendments, or exhibits provided. No financial metrics, positive or negative changes, or quantified impacts are disclosed.
28-01-2026
Repare Therapeutics Inc. filed an 8-K on January 28, 2026, announcing the completion of an acquisition or disposition of assets (Item 2.01), changes in control of the registrant (Item 5.01), and changes in directors or officers including compensatory arrangements (Item 5.02). However, the filing also discloses notice of delisting or failure to satisfy listing standards (Item 3.01) and material modifications to rights of security holders (Item 3.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). These items indicate a transformative transaction resulting in delisting and altered shareholder rights.
28-01-2026
MVB Financial Corp filed an 8-K on January 28, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material non-public information, with exhibits likely including a press release or presentation. No specific financial metrics, transactions, quantitative data, positive or negative changes, or operational details are disclosed in the provided filing information.
28-01-2026
NATIONAL FUEL GAS CO filed an 8-K on January 28, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing likely includes voluntary disclosure of material non-public information with attached exhibits, but no specific details, financial metrics, transactions, or performance data are provided in the filing summary. No positive or negative metrics disclosed.
28-01-2026
dMY Squared Technology Group, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001829126-26-000711) under Item 8.01 reporting Other Events. No specific details on the nature of the events, financial metrics, transactions, or impacts are disclosed in the provided filing information. Sector is not specified.
28-01-2026
UPEXI, INC. filed a Form 8-K on January 28, 2026, under Item 5.03 reporting amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, financial impacts, or strategic implications of the changes are provided.
28-01-2026
ArrowMark Financial Corp. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative changes, or performance comparisons are disclosed in the provided filing summary. This is a multi-item informational filing with no specified sector impacts.
- Β·AccNo: 0001999371-26-001905
- Β·File Size: 3 MB
- Β·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
28-01-2026
Ryman Hospitality Properties, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreements, transaction values, financial impacts, or other metrics are provided in the filing summary. This multi-item filing reports material events without quantified positive or negative metrics.
28-01-2026
Nomadar Corp. filed a Form 8-K on January 28, 2026 (AccNo: 0001493152-26-004053), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, financial metrics, or exhibits provided in the summary. No quantitative data, guidance, or scheduled events are disclosed.
28-01-2026
Enveric Biosciences, Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, which may imply dilutive financing but lacks specific details. Item 9.01 includes financial statements and exhibits. No quantitative transaction values, share counts, or financial impacts are disclosed.
28-01-2026
International Media Acquisition Corp. filed an 8-K on 2026-01-28 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed. Sector is not specified.
28-01-2026
Allbirds, Inc. filed an 8-K on January 28, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, or any quantitative metrics are provided in the filing summary. This appears to be an informational filing with no disclosed positive or negative financial impacts.
28-01-2026
VEECO INSTRUMENTS INC filed an 8-K on January 28, 2026 under Item 8.01 Other Events. No specific details, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
28-01-2026
TETRA TECH INC filed an 8-K on 2026-01-28 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating disclosure of financial results and related exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are mentioned. No positive or negative performance indicators are provided in the filing details.
28-01-2026
Axcelis Technologies Inc filed an 8-K on January 28, 2026, under Item 8.01 Other Events, indicating a voluntary disclosure of an unspecified material event. No quantitative financial metrics, transaction details, guidance changes, or operational impacts are disclosed. The filing lacks specific information on positives, negatives, or flat performance across any metrics.
28-01-2026
FTAI Aviation Ltd. filed an 8-K on 2026-01-28 (AccNo: 0001140361-26-002691, Size: 215 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics are mentioned.
28-01-2026
COFFEE HOLDING CO INC filed an 8-K on January 28, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements/exhibits are provided.
28-01-2026
Zoned Properties, Inc. filed an 8-K on January 28, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as affected positions, names, reasons for change, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
28-01-2026
AVAX ONE TECHNOLOGY LTD. filed a Form 8-K on January 28, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary.
28-01-2026
INTELLIGENT BIO SOLUTIONS INC. filed an 8-K on January 28, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or performance data disclosed in the provided filing information. No positive or negative metrics are mentioned.
28-01-2026
PROVIDENT FINANCIAL SERVICES INC filed an 8-K on January 28, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, financial metrics, transactions, or quantitative data are explicitly stated in the provided filing information. This appears to be a multi-item informational filing with attached exhibits, but content details are not disclosed.
28-01-2026
Ovintiv Inc. filed a Form 8-K on January 28, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific transaction details, financial metrics, or quantitative data are disclosed in the filing summary. This multi-item filing complies with Reg FD to ensure broad dissemination of material information.
28-01-2026
Supernus Pharmaceuticals, Inc. filed an 8-K on January 28, 2026, under Item 9.01 Financial Statements and Exhibits (AccNo: 0001628280-26-003907, Size: 620 KB). No specific financial statements, exhibits, transactions, metrics, or material events are detailed in the provided filing information. This is an informational disclosure with no quantitative data or directional implications disclosed.
28-01-2026
RGC Resources Inc filed an 8-K on January 28, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely reporting results from a shareholder meeting. Item 8.01 covers other events, while Item 9.01 references financial statements and exhibits, but no specific details, outcomes, or metrics are provided.
28-01-2026
Southern Copper Corp filed an 8-K on January 28, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing information provided. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.
28-01-2026
CalciMedica, Inc. filed a Form 8-K on January 28, 2026 (AccNo: 0001193125-26-027462), reporting solely under Item 8.01 Other Events. No details on the specific event, financial metrics, transactions, or impacts are disclosed. No quantitative data or period-over-period comparisons provided.
28-01-2026
SenesTech, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other material data are mentioned.
28-01-2026
Bluerock Acquisition Corp. filed an 8-K on January 28, 2026 (AccNo: 0001213900-26-008946), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale are provided in the filing summary. Sector is not specified, and no quantitative metrics, comparisons, or scheduled events are mentioned.
28-01-2026
28-01-2026
Altimmune, Inc. filed an 8-K on 2026-01-28 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.
28-01-2026
Assurant, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or financial impacts are disclosed.
28-01-2026
DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.
28-01-2026
EGH Acquisition Corp. filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007494, Size: 331 KB) disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory pathways, or shareholder impacts are explicitly stated in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.
- Β·AccNo: 0001104659-26-007494
- Β·Filing date: 2026-01-28
- Β·Sector: not specified
28-01-2026
California Water Service Group filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007493, size 259 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No positive or negative performance metrics, period-over-period changes, or strategic implications are mentioned.
28-01-2026
EQUITY LIFESTYLE PROPERTIES INC filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003909, Size: 137 KB) reporting solely under Item 8.01 Other Events. No core event details, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure with no specified timing relative to the event.
- Β·Filing Accession Number: 0001628280-26-003909
- Β·Filing Size: 137 KB
28-01-2026
OIL STATES INTERNATIONAL, INC filed a Form 8-K on 2026-01-28 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, financial obligation, dollar values, strategic importance, or market impacts disclosed in the provided information. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 269 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC